Life Sciences talk would be spot on for me too, please.

Sandra McLaughlin

From: [email protected] 
[mailto:[email protected]] On Behalf Of [email protected]
Sent: 26 March 2015 15:24
To: [email protected]
Subject: Re: [gpfsug-discuss] EXTERNAL: Potential talks for GPFS UG May 20th

As well as supporting the efforts of our friends at NERSC I think should be a 
good interesting talk.

Mark Roberts

________________________________
From: 
[email protected]<mailto:[email protected]> 
[mailto:[email protected]] On Behalf Of Ross Keeping3
Sent: 26 March 2015 15:00
To: [email protected]<mailto:[email protected]>
Subject: EXTERNAL: [gpfsug-discuss] Potential talks for GPFS UG May 20th

Hi

There are a couple of talks we could include in the one day GPFS UG on May 20th.

We'd appreciate some feedback on whether there is any interest or objection to 
including these.

These are:
1) Tivoli Storage Productivity Center Technical Demo: A tool for managing 
heterogeneous storage infrastructures and specifically GPFS. Can read more here 
http://www-03.ibm.com/software/products/en/tivostorprodcent

2) GPFS for life sciences: A member of NERSC would like to talk about their 
efforts to improve GPFS file systems for a life sciences workload - 
specifically genomic sequencing and analysis that ensues. Details about life 
science workflow and requirements will be provided so the listener may 
understand the aspects of GPFS that are important.

Cheers,
Ross
Unless stated otherwise above:
IBM United Kingdom Limited - Registered in England and Wales with number 741598.
Registered office: PO Box 41, North Harbour, Portsmouth, Hampshire PO6 3AU

___________________________________________________ 
____________________________ The information in this email and in any 
attachment(s) is commercial in confidence. If you are not the named 
addressee(s) or if you receive this email in error then any distribution, 
copying or use of this communication or the information in it is strictly 
prohibited. Please notify us immediately by email at 
admin.internet(at)awe.co.uk, and then delete this message from your computer. 
While attachments are virus checked, AWE plc does not accept any liability in 
respect of any virus which is not detected. AWE Plc Registered in England and 
Wales Registration No 02763902 AWE, Aldermaston, Reading, RG7 4PR

________________________________

AstraZeneca UK Limited is a company incorporated in England and Wales with 
registered number: 03674842 and a registered office at 2 Kingdom Street, 
London, W2 6BD.

Confidentiality Notice: This message is private and may contain confidential, 
proprietary and legally privileged information. If you have received this 
message in error, please notify us and remove it from your system and note that 
you must not copy, distribute or take any action in reliance on it. Any 
unauthorised use or disclosure of the contents of this message is not permitted 
and may be unlawful.

Disclaimer: Email messages may be subject to delays, interception, non-delivery 
and unauthorised alterations. Therefore, information expressed in this message 
is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by 
an authorised representative independent of this message. No contractual 
relationship is created by this message by any person unless specifically 
indicated by agreement in writing other than email.

Monitoring: AstraZeneca UK Limited may monitor email traffic data and content 
for the purposes of the prevention and detection of crime, ensuring the 
security of our computer systems and checking compliance with our Code of 
Conduct and policies.
_______________________________________________
gpfsug-discuss mailing list
gpfsug-discuss at gpfsug.org
http://gpfsug.org/mailman/listinfo/gpfsug-discuss

Reply via email to